ESR1 and breast cancer: With at least 70% of breast cancers exhibiting high ER expression, which is known to contribute to tumor growth and progression (12), Beatson’s findings revolutionized the management of breast cancer, leading to the discovery of the selective ER modulator (SERM), tamoxifen.